ARID1B and central nervous system disorder: This work on APBD is our third study using a LC–MS/MS proteomic analysis of lymphoblasts of a rare genetic CNS disorder; it was preceded by analyses of lymphoblast proteomes of persons with neurologic diseases due to mutations of ARID1B and HERC2 (44, 45).